XML 108 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Significant Accounting Policies (Details Narrative)
12 Months Ended
Dec. 31, 2020
USD ($)
Dec. 31, 2020
ILS (₪)
Dec. 31, 2019
USD ($)
Dec. 31, 2020
ILS (₪)
Dec. 31, 2019
ILS (₪)
Restricted cash $ 22,395   $ 38,194    
Allownace for doubtful accounts 26,553   24,702    
Impaiement expenses      
Severance expenses 7,419   24,000    
Cumulative research and development grants received 150,678        
Revenues 232,274   175,823    
Israeli Innovation Authority [Member]          
Revenues      
NIS [Member]          
Restricted cash | ₪       ₪ 72,000 ₪ 132,000
Cumulative research and development grants received | ₪   ₪ 484,429